Regulations.gov document
Exhibit 11 The Pharmaletter, ANSM continues investigations into Bial clinical trial death…
Supporting & Related Material · FDA-2015-P-2820 · posted Mar 21, 2016
Key facts
| Document ID | FDA-2015-P-2820-0064 |
|---|---|
| Title | Exhibit 11 The Pharmaletter, ANSM continues investigations into Bial clinical trial death, March 10, 2016 re: Amendment from Center for Responsible Science |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2015-P-2820 |
| Posted | Mar 21, 2016 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: